[Treatment of intestinal dysbiosis with Hylakombun].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria; D001688:Biological Products / Q000627:therapeutic use*; D004064:Digestive System / Q000382:microbiology*; D004338:Drug Combinations; D013293:Enterococcus faecalis; D004926:Escherichia coli; D005243:Feces / Q000382:microbiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007779:Lactobacillus acidophilus; D008297:Male; D008875:Middle Aged; D010194:Pancreatin / Q000008:administration & dosage*; D010208:Papaverine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use
D001688:Biological Products; D004338:Drug Combinations; D011804:Quinolines; D010194:Pancreatin; D010208:Papaverine
Behandlung der Darmdysbiose mit Hylakombun.